Careers
Contact Us
Facebook
Twitter
LinkedIn
Home
About
Mission
Leaders
Science
Pipeline
Manufacturing
The AIM
TM
Vector
Clinical Trials
Overview
Recessive Dystrophic Epidermolysis Bullosa (RDEB)
Patients & Families
Patient Advocacy & Community Engagement (PACE)
Our Focus
Resources
Our Inspiration
Access Policy
Investors & Media
Overview
News / Events
Company Information
Financial Information
Stock Data
SEC Filings
Corporate Governance
Careers
Contact Us
×
Home
About
Mission
Leaders
Science
Pipeline
Manufacturing
The AIM
TM
Vector
Clinical Trials
Overview
Recessive Dystrophic Epidermolysis Bullosa (RDEB)
Patients & Families
Patient Advocacy & Community Engagement (PACE)
Our Focus
Resources
Our Inspiration
Access Policy
Investors & Media
Overview
News / Events
Company Information
Financial Information
Stock Data
SEC Filings
Corporate Governance
Careers
Contact Us
News / Events
Investors
Investors & Media
Overview
News / Events
Overview
Press Releases
Events
Email Alerts
Company Info
Overview
Profile
Presentations
Management Team
Scientific Advisory Board
Contacts
Financial Info
Overview
Financial Results
Stock Data
Overview
Quote
Charts
Historical Data
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Overview
Board of Directors
Board Committees
Governance Documents
Investor Tools
Email Alerts
Tear Sheet
Contacts
RSS News Feed
News / Events
Overview
Press Releases
Events
Email Alerts
Recent News
View All News
Abeona Therapeutics Reports Third Quarter 2022 Financial Results
November 14, 2022
Abeona Therapeutics Announces $35 Million Private Placement Financing
November 3, 2022
View All News
Email Alerts
Sign up for email alerts for Press Releases & SEC Filings
Sign Up
